Growth Metrics

INVO Fertility (IVF) EBITDA Margin (2011 - 2025)

INVO Fertility (IVF) reported EBITDA Margin of 91.29% for Q3 2025, down 238.0% year-over-year from 66.15% in Q3 2024, and up 42.5% on a QoQ basis from 158.76% in Q2 2025.

INVO Fertility (IVF) has 15 years of EBITDA Margin data on file, last reported at 91.29% in Q3 2025.

  • Quarterly EBITDA Margin fell 238.0% year-over-year to 91.29% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 271.63% (down 17409.0% YoY) and the FY2024 annual result came in at 27.68%, up 19370.0% from the prior year.
  • EBITDA Margin improved to 91.29% in Q3 2025 per IVF's latest filing, from 158.76% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 2058.28% in Q4 2022 and bottomed at 1820.37% in Q2 2022.
  • The 5-year median for EBITDA Margin is 158.76% (2025), against an average of 390.62%.
  • The widest annual swing landed in 2022, when EBITDA Margin soared 191500 bps; it then sank 216593 bps in 2023.
  • Tracing IVF's EBITDA Margin over 5 years: stood at 143.29% in 2021, then surged by 1336 bps to 2058.28% in 2022, then plunged by 105 bps to 107.65% in 2023, then jumped by 253 bps to 164.81% in 2024, then plunged by 155 bps to 91.29% in 2025.
  • Per Business Quant, the three latest IVF EBITDA Margin figures stand at 91.29% (Q3 2025), 158.76% (Q2 2025), and 1043.09% (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00 -91.29%

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -91.29%
Jun 30, 2025 -158.76%
Mar 31, 2025 -1,043.09%
Dec 31, 2024 164.81%
Sep 30, 2024 -88.91%
Jun 30, 2024 -99.47%
Mar 31, 2024 -94.24%
Dec 31, 2023 -107.65%
Sep 30, 2023 -88.81%
Jun 30, 2023 -647.76%
Mar 31, 2023 -657.23%
Dec 31, 2022 2,058.28%
Sep 30, 2022 -1,064.99%
Jun 30, 2022 -1,820.37%
Mar 31, 2022 -1,656.55%
Dec 31, 2021 143.29%
Sep 30, 2021 -1,037.72%
Jun 30, 2021 -903.78%
Mar 31, 2021 -227.51%
Dec 31, 2020 -908.23%
Sep 30, 2020 -376.51%
Jun 30, 2020 -430.97%
Mar 31, 2020 -539.15%
Dec 31, 2019 -225.47%
Sep 30, 2019 -208.31%
Jun 30, 2019 -9.99%
Mar 31, 2019 -184.29%
Dec 31, 2018 -331.28%
Sep 30, 2018 -151.86%
Jun 30, 2018 -1,624.58%
Mar 31, 2018 -134.71%
Dec 31, 2017 -242.16%
Sep 30, 2017 -211.52%
Jun 30, 2017 -164.84%
Mar 31, 2017 -319.11%
Dec 31, 2016 -2,840.13%
Sep 30, 2016 -1,162.99%
Jun 30, 2016 -26,663.29%
Mar 31, 2016 -997.76%
Sep 30, 2015 -4,725.98%
Jun 30, 2015 -1,935.51%
Mar 31, 2015 -3,637.05%
Sep 30, 2014 -2,202.15%
Jun 30, 2014 -8,039.96%
Mar 31, 2014 -1,080.06%
Dec 31, 2013 -938.80%
Sep 30, 2013 -41,869.70%
Jun 30, 2013 -4,135.31%
Mar 31, 2013 -2,312.99%
Dec 31, 2012 -401.14%
Sep 30, 2012 -4,424.01%
Jun 30, 2012 -1,262.55%
Mar 31, 2012 -1,032.22%
Dec 31, 2011 -4,036.48%
Sep 30, 2011 -1,339.39%
Jun 30, 2011 -938.90%